Hollestelle, Marieke J
van der Graaf, Rieke
Sturkenboom, Miriam CJM
van Delden, Johannes JM
Funding for this research was provided by:
Innovative Medicines Initiative (Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520, Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520, Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821520)
Article History
Received: 21 January 2023
Accepted: 20 June 2023
First Online: 27 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: Author MS is leading a department that conducts regulatory required research for COVID-19 vaccine manufacturers based on the ENCePP code of conduct and is project coordinator of IMI-ConcePTION. The other co-authors declared no competing interests for this work.